azacitidine has been researched along with Disseminated Fungal Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, LY; Chen, TT; Chou, CH; Ho, MW; Lien, MY; Lin, CC; Wang, ST; Yeh, SP | 1 |
| Mohamed, A; Nguyen, P; Safdar, J; Soubani, A | 1 |
| Cardamone, L; Paul, E; Rogers, B; Shaw, B; Shepherd, S; Shortt, J; Tey, A | 1 |
| Arnan, M; Duarte, RF; Pomares, H; Sánchez-Ortega, I; Sureda, A | 1 |
1 review(s) available for azacitidine and Disseminated Fungal Infection
| Article | Year |
|---|---|
Azacitidine-induced pneumonitis and literature review.
Topics: Aged; Azacitidine; Enzyme Inhibitors; Female; Humans; Invasive Fungal Infections; Lung; Pneumonia; Radiography, Thoracic; Tomography, X-Ray Computed | 2020 |
3 other study(ies) available for azacitidine and Disseminated Fungal Infection
| Article | Year |
|---|---|
High rate of invasive fungal infections during early cycles of azacitidine for patients with acute myeloid leukemia.
Topics: Antifungal Agents; Azacitidine; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Neutropenia; Retrospective Studies | 2022 |
Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Azacitidine; Disease Susceptibility; Female; Humans; Incidence; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neutropenia; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome | 2021 |
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic-Myeloproliferative Diseases; Neutropenia; Numbers Needed To Treat; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Triazoles | 2016 |